KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abbott Laboratories (ABT) Equity Average (2016 - 2025)

Historic Equity Average for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $51.0 billion.

  • Abbott Laboratories' Equity Average rose 2827.69% to $51.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $51.0 billion, marking a year-over-year increase of 2827.69%. This contributed to the annual value of $43.4 billion for FY2024, which is 1706.71% up from last year.
  • Abbott Laboratories' Equity Average amounted to $51.0 billion in Q3 2025, which was up 2827.69% from $49.9 billion recorded in Q2 2025.
  • Abbott Laboratories' 5-year Equity Average high stood at $51.0 billion for Q3 2025, and its period low was $30.7 billion during Q1 2021.
  • In the last 5 years, Abbott Laboratories' Equity Average had a median value of $37.3 billion in 2023 and averaged $38.7 billion.
  • In the last 5 years, Abbott Laboratories' Equity Average skyrocketed by 316.68% in 2023 and then surged by 2827.69% in 2025.
  • Quarter analysis of 5 years shows Abbott Laboratories' Equity Average stood at $33.1 billion in 2021, then increased by 7.52% to $35.6 billion in 2022, then grew by 7.56% to $38.3 billion in 2023, then increased by 14.91% to $44.0 billion in 2024, then increased by 16.11% to $51.0 billion in 2025.
  • Its Equity Average was $51.0 billion in Q3 2025, compared to $49.9 billion in Q2 2025 and $48.5 billion in Q1 2025.